Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kromh is a San Diego-based biotechnology company specializing in high-throughput single-cell multi-omics and spatial biology solutions. The company has developed a proprietary platform that enables the simultaneous detection and measurement of proteins and RNA transcripts at the single-cell level. This technology provides researchers with a comprehensive understanding of cellular heterogeneity and function within complex tissues, which is critical for advancements in oncology, immunology, and neuroscience. Kromh offers both specialized kits and analysis services to academic and pharmaceutical researchers to accelerate drug discovery and biomarker identification.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KROMH.